You searched for "glaucoma care"
Choroid and retinal changes post COVID-19
The authors aimed to evaluate choroid and inner neural layers in people previously recovered from Covid-19 compared to healthy controls using optical coherence tomography (OCT) over a six-month period. They recruited 96 people: 56 with Covid-19 at least three months...Glaucoma UK launches new step-by-step guide to help patients with eye drops
3 March 2022
Glaucoma UK, the leading charity in the country for people living with glaucoma, has launched a new easy read guide to help patients put in their eye drops.
Blood pressure association with primary open angle glaucoma severity
31 May 2024
| Su Young
|
EYE - Glaucoma
This prospective observational study involved 47 patients diagnosed with primary open angle glaucoma (POAG) examined to investigate their postural blood pressure response and its potential correlation with the severity of glaucomatous optic neuropathy (GON). Participants underwent intraocular pressure and systemic...
Relationship between nocturnal intraocular pressure elevation and diurnal intraocular pressure level in NTG patients
1 October 2015
| Wai Siene Ng
|
EYE - Glaucoma
This group studies Korean normo-tension glaucoma (NTG) patients over a 24-hour period to assess if there was a relationship between nocturnal intraocular pressure (IOP) and diurnal IOP. They have previously suggested differences in diurnal IOP may have varying mechanisms of...
A review of chromosome 9p21 POAG susceptibility locus
1 August 2014
| Anjali Gupta
|
EYE - Glaucoma
Primary open angle glaucoma (POAG) is a genetically complex disease and the overall phenotype is influenced by multiple traits including intraocular pressure (IOP), central corneal thickness and structural features of the optic nerve head. Therefore, genes affecting any of these...
Mitomycin C versus 5-FU as an adjunctive treatment for trabeculectomy
1 February 2014
| Anjali Gupta
|
EYE - Glaucoma
Antifibrotic agents are used during trabeculectomy (TRAB) to improve long-term surgical success by reducing fibrosis of subconjunctival and episcleral tissue. The purpose of this meta-analysis was to directly compare the efficacy and safety of the two most frequently used antifibrotic...
Glaucoma UK announces grant for Health and Social Care Professionals to further glaucoma research
15 March 2023
Glaucoma UK is pleased to announce that applications for its Health and Social Care Professionals Research Award are now open.
New Opportunity for Glaucoma Researchers: Apply Now for Glaucoma UK's Open Call Research Award
Glaucoma UK announces the Open Call Research Award 2023, offering up to £50,000 in funding for glaucoma-related research.Glaucoma UK’s National Eye Health Week campaign highlights the significance of timely information in safeguarding eyesight
18 September 2023
|
Glaucoma UK, National Eye Health Week, Joanne Creighton, campaign, learning, eyesight
Glaucoma UK’s campaign for National Eye Health Week 2023, which will run from 18-24 September, focuses on delivering essential bitesize information about glaucoma that can be read or viewed in under one minute.
Glaucoma UK’s Road Safety Week campaign encourages people to keep their vision road-ready
Road Safety Week will run from 19-25 November 2023 and Glaucoma UK, a registered charity that provides support for everyone living with glaucoma is encouraging people to keep their vision road-ready.Glaucoma UK announces United Kingdom & Eire Glaucoma Society (UKEGS) Research Award 2024
Glaucoma UK is delighted to announce that this year’s UKEGS Research Award is now open to UKEGS members. The award, funded by Glaucoma UK and UKEGS, offers up to £50,000 for projects aimed at impacting patient care, scientific advancement, or understanding of glaucoma.The approach to angle-closure glaucoma
1 October 2016
| Kaivon Pakzad-Vaezi
|
EYE - Glaucoma
Further to my last article in Eye News (print issue) describing the diagnostic approaches to various clinical scenarios in glaucoma, the approach to angle-closure glaucoma (ACG), a situation terrifying for patient and registrar alike, will be discussed. Please refer to...